More information: Hyejin Kim et al, Lipid nanoparticle-mediated mRNA delivery to CD34+ cells in rhesus monkeys, Nature Biotechnology (2024). DOI: 10.1038/s41587-024-02470-2 Provided by Georgia ...

It has been shown that SNALPs entered cells ... nanoparticles and viral vectors. Function-engineerable nanoparticles in combination with the advantageous effects of various functional lipid ...

Titania nanoparticles damage enveloped viruses by directly binding with membrane phospholipids – a previously unknown mode of antiviral action ...

Scientists have identified nanoparticles that latch onto and destroy virus membranes, opening new possibilities for antiviral ...

Every time a shuttle docks with the International Space Station (ISS), a precise and intricate process takes place between ...

A similar challenge arises at the microscopic level when lipid nanoparticles (LNPs)—the revolutionary drug delivery vehicles behind the COVID-19 vaccines—attempt to deliver mRNA to cells.

Efforts to design new ionizable lipids aim to reduce immune responses and improve the efficiency of drug release within cells. Automating production processes is another focus to meet the increasing ...

Genetic medicines could treat certain diseases, however, the current delivery systems available—viral vectors and lipid nanoparticles (LNPs)—pose unique challenges for gene therapy applications. For ...

Their distinctive properties such as innate stability, low immunogenicity, biocompatibility, and excellent tissue or cell penetration capabilities allow them to function as superior natural ...

Researchers at Tel Aviv University have achieved a major breakthrough in drug delivery: they have successfully transported lipid nanoparticles ... straight to target cells, avoiding the liver.

Once thought to be little more than blobs of fat inside eukaryotic cells, lipid droplets may in fact provide a first line of defence against invading pathogens, according to evidence published today ...